BR9408305A - Composto composição farmacêutica processos para tratamento de aids e da infecção por hiv para preparação da infecção por hiv e para inibição de protease de hiv e combinação de compostos - Google Patents
Composto composição farmacêutica processos para tratamento de aids e da infecção por hiv para preparação da infecção por hiv e para inibição de protease de hiv e combinação de compostosInfo
- Publication number
- BR9408305A BR9408305A BR9408305A BR9408305A BR9408305A BR 9408305 A BR9408305 A BR 9408305A BR 9408305 A BR9408305 A BR 9408305A BR 9408305 A BR9408305 A BR 9408305A BR 9408305 A BR9408305 A BR 9408305A
- Authority
- BR
- Brazil
- Prior art keywords
- hiv
- hiv infection
- compounds
- treatment
- aids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16801393A | 1993-12-15 | 1993-12-15 | |
| US17047593A | 1993-12-20 | 1993-12-20 | |
| PCT/US1994/014187 WO1995016688A1 (en) | 1993-12-15 | 1994-12-12 | Hiv protease inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9408305A true BR9408305A (pt) | 1997-08-26 |
Family
ID=26863718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9408305A BR9408305A (pt) | 1993-12-15 | 1994-12-12 | Composto composição farmacêutica processos para tratamento de aids e da infecção por hiv para preparação da infecção por hiv e para inibição de protease de hiv e combinação de compostos |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US5646148A (pt) |
| EP (1) | EP0734387B1 (pt) |
| JP (1) | JP3000564B2 (pt) |
| KR (1) | KR100234863B1 (pt) |
| CN (1) | CN1046727C (pt) |
| AT (1) | ATE215952T1 (pt) |
| AU (1) | AU692509B2 (pt) |
| BG (1) | BG62093B1 (pt) |
| BR (1) | BR9408305A (pt) |
| CA (1) | CA2178760C (pt) |
| CZ (1) | CZ288312B6 (pt) |
| DE (1) | DE69430385T2 (pt) |
| ES (1) | ES2174921T3 (pt) |
| FI (1) | FI962488A (pt) |
| HU (1) | HUT74681A (pt) |
| NZ (1) | NZ278201A (pt) |
| PL (1) | PL314984A1 (pt) |
| SK (1) | SK75796A3 (pt) |
| WO (1) | WO1995016688A1 (pt) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE299707T1 (de) | 1995-11-13 | 2005-08-15 | Vitaleech Bioscience N V | Antivirale isolate von blutegeln |
| MY126358A (en) * | 1996-03-22 | 2006-09-29 | Glaxo Group Ltd | Compositions comprising vx478 and a water soluble tocopherol derivative such as vitamin e-tpgs |
| TW438799B (en) * | 1997-05-29 | 2001-06-07 | Merck & Co Inc | HIV protease inhibitor |
| CO4940492A1 (es) * | 1997-05-29 | 2000-07-24 | Merck & Co Inc | Inhibidor de proteasa de vih |
| CO4970782A1 (es) * | 1997-11-13 | 2000-11-07 | Merck & Co Inc | Terapia combinada para el tratamiento del sida |
| US6180634B1 (en) | 1997-11-13 | 2001-01-30 | Merck & Co., Inc. | Combination therapy for the treatment of AIDS |
| US6251906B1 (en) | 1998-05-15 | 2001-06-26 | Abbott Laboratories | Retroviral protease inhibiting compounds |
| FR2780649B1 (fr) | 1998-07-06 | 2001-03-09 | Univ Paris Vii Denis Diderot | Derives de la piperazine pour l'inhibition de la replication du virus de l'immunodeficience humaine |
| GB2341385A (en) | 1998-09-14 | 2000-03-15 | Merck & Co Inc | Recovery of iodide from chemical process waste water |
| US6440946B1 (en) * | 1999-02-25 | 2002-08-27 | Takeda Chemical Industries, Ltd. | Multiple-agents-binding compound, production and use thereof |
| US6589962B1 (en) | 1999-07-20 | 2003-07-08 | Merck & Co., Inc. | Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof |
| US6642237B1 (en) | 1999-11-24 | 2003-11-04 | Merck & Co., Inc. | Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides and uses thereof |
| US6482952B2 (en) | 2000-06-20 | 2002-11-19 | Merck & Co., Inc. | Process for preparing acetonides |
| US7049146B2 (en) | 2000-11-14 | 2006-05-23 | Facet Analytical Services And Technology, Llc | Calibration standards, methods, and kits for water determination |
| US7122376B2 (en) * | 2001-11-01 | 2006-10-17 | Facet Analytical Services And Technology, Llc | Calibration standards, methods, and kits for water determination |
| US20040131504A1 (en) * | 2002-09-17 | 2004-07-08 | Landers James P. | Remote temperature sensing of small volume and related apparatus thereof |
| GB0720503D0 (en) * | 2007-10-22 | 2007-11-28 | Angeletti P Ist Richerche Bio | New compound |
| US20130115237A1 (en) | 2010-06-09 | 2013-05-09 | Vaccine Technologies, Incorporated | Therapeutic immunization in hiv infected subjects to augment antiretroviral treatment |
| CN108178764A (zh) * | 2018-01-09 | 2018-06-19 | 天津科技大学 | 呋喃并[2,3-b]吡啶类化合物及无金属催化的合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL89900A0 (en) * | 1988-04-12 | 1989-12-15 | Merck & Co Inc | Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them |
| WO1993008184A1 (en) * | 1991-10-23 | 1993-04-29 | Merck & Co., Inc. | Hiv protease inhibitors |
| EP0541168B1 (en) * | 1991-11-08 | 1998-03-11 | Merck & Co. Inc. | HIV protease inhibitors useful for the treatment of aids |
| US5413999A (en) * | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
| SI9420017B (sl) * | 1993-03-31 | 2003-12-31 | Merck & Co. Inc. | Inhibitorji proteaze hiv-a v farmacevtskih kombinacijah za zdravljenje aids-a |
-
1994
- 1994-12-12 CZ CZ19961586A patent/CZ288312B6/cs not_active IP Right Cessation
- 1994-12-12 CN CN94194954A patent/CN1046727C/zh not_active Expired - Fee Related
- 1994-12-12 JP JP7516855A patent/JP3000564B2/ja not_active Expired - Fee Related
- 1994-12-12 CA CA002178760A patent/CA2178760C/en not_active Expired - Fee Related
- 1994-12-12 WO PCT/US1994/014187 patent/WO1995016688A1/en active Search and Examination
- 1994-12-12 NZ NZ278201A patent/NZ278201A/en unknown
- 1994-12-12 DE DE69430385T patent/DE69430385T2/de not_active Expired - Fee Related
- 1994-12-12 SK SK757-96A patent/SK75796A3/sk unknown
- 1994-12-12 ES ES95905886T patent/ES2174921T3/es not_active Expired - Lifetime
- 1994-12-12 PL PL94314984A patent/PL314984A1/xx unknown
- 1994-12-12 HU HU9601649A patent/HUT74681A/hu unknown
- 1994-12-12 EP EP95905886A patent/EP0734387B1/en not_active Expired - Lifetime
- 1994-12-12 BR BR9408305A patent/BR9408305A/pt not_active Application Discontinuation
- 1994-12-12 AT AT95905886T patent/ATE215952T1/de not_active IP Right Cessation
- 1994-12-12 KR KR1019960703165A patent/KR100234863B1/ko not_active IP Right Cessation
- 1994-12-12 AU AU14331/95A patent/AU692509B2/en not_active Ceased
-
1995
- 1995-03-29 US US08/412,509 patent/US5646148A/en not_active Expired - Fee Related
-
1996
- 1996-06-05 BG BG100643A patent/BG62093B1/bg unknown
- 1996-06-14 FI FI962488A patent/FI962488A/fi unknown
-
1997
- 1997-04-08 US US08/825,787 patent/US5807841A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NZ278201A (en) | 1998-01-26 |
| WO1995016688A1 (en) | 1995-06-22 |
| CZ158696A3 (en) | 1996-11-13 |
| EP0734387A4 (en) | 1997-03-05 |
| EP0734387B1 (en) | 2002-04-10 |
| CA2178760C (en) | 2000-08-01 |
| PL314984A1 (en) | 1996-09-30 |
| AU1433195A (en) | 1995-07-03 |
| KR100234863B1 (ko) | 1999-12-15 |
| DE69430385T2 (de) | 2002-11-07 |
| ES2174921T3 (es) | 2002-11-16 |
| AU692509B2 (en) | 1998-06-11 |
| HUT74681A (en) | 1997-01-28 |
| CN1046727C (zh) | 1999-11-24 |
| JPH09506619A (ja) | 1997-06-30 |
| BG100643A (bg) | 1997-02-28 |
| US5646148A (en) | 1997-07-08 |
| CA2178760A1 (en) | 1995-06-22 |
| HU9601649D0 (en) | 1996-08-28 |
| JP3000564B2 (ja) | 2000-01-17 |
| DE69430385D1 (de) | 2002-05-16 |
| CZ288312B6 (en) | 2001-05-16 |
| FI962488A0 (fi) | 1996-06-14 |
| EP0734387A1 (en) | 1996-10-02 |
| FI962488A (fi) | 1996-06-14 |
| SK75796A3 (en) | 1997-05-07 |
| US5807841A (en) | 1998-09-15 |
| CN1142827A (zh) | 1997-02-12 |
| BG62093B1 (bg) | 1999-02-26 |
| ATE215952T1 (de) | 2002-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2725392A (en) | Hiv protease inhibitors | |
| ATE377011T1 (de) | Gamma-hydroxy-2-(fluoralkylaminocarbonyl)-1- piperazinpentanamide als hiv-proteasehemmer | |
| BR9408305A (pt) | Composto composição farmacêutica processos para tratamento de aids e da infecção por hiv para preparação da infecção por hiv e para inibição de protease de hiv e combinação de compostos | |
| ATE252081T1 (de) | Neue hiv-protease-inhibitoren | |
| MY109834A (en) | Benzoxazinones as inhibitors of hiv reverse transcriptase | |
| BR9406503A (pt) | Combinação de compostos composição farmacêutica e processos para tratar aids para evitar e para tratar infecção por HIV e para inibir protease de HIV | |
| WO1996000068A3 (en) | Combination therapy for hiv infection | |
| EP0774969B8 (en) | Hiv protease inhibitor combination | |
| WO2002096359A3 (en) | Piperazine pentanamide hiv protease inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn |